Evidence map›Paper›PMID 32856526›Full record

ArticleJournal of the American Heart Association2020

Heart Rate-Induced Myocardial Ca

Daniel N Silverman, Mehdi Rambod, Daniel L Lustgarten, Robert Lobel, Martin M LeWinter, Markus Meyer

Registry-linked trialAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05745337 (Improving Outcomes in Atrial Fibrillation Patients Aided by Implantable Cardiac Monitor), which is not on this map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05745337 phase1unknown statusnot on this mapstarted 2023, after this paper: background citation

Improving Outcomes in Atrial Fibrillation Patients Aided by Implantable Cardiac Monitor: Evaluation of Chronic Beta-blocker Use Versus As-needed Pharmacological Rate Control

TypeinterventionalSponsorUniversity of VermontRan2023 to 2025Enrolled20ConditionsAtrial Fibrillation, Diastolic Dysfunction, HFpEF - Heart Failure With Preserved Ejection FractionArmsAs needed pharmacological rate control with beta-blocker (metoprolol tartrate, metoprolol succinate) or calcium channel blocker (diltiazem, verapamil)
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Review
  9. A perspective on the future of heart failure research.Journal of molecular and cellular cardiology plus · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Personalized accelerated physiologic pacing.European heart journal supplements : journal of the European Society of Cardiology · 2023
    Article
  20. Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation.International journal of cardiology. Cardiovascular risk and prevention · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniel N SilvermanDivision of Cardiology Department of Medicine Medical University of South Carolina Charleston SC.
Mehdi RambodCardiology Division Department of Medicine Larner College of Medicine at the University of Vermont Burlington VT.
Daniel L LustgartenCardiology Division Department of Medicine Larner College of Medicine at the University of Vermont Burlington VT.
Robert LobelCardiology Division Department of Medicine Larner College of Medicine at the University of Vermont Burlington VT.
Martin M LeWinterCardiology Division Department of Medicine Larner College of Medicine at the University of Vermont Burlington VT.
Markus MeyerCardiology Division Department of Medicine Larner College of Medicine at the University of Vermont Burlington VT.

Funding

Myofilament-based mechanisms of diastolic dysfunction in HFpEFR01HL118524 · NHLBI · UNIVERSITY OF ARIZONA · PI GRANZIER, HENK L., LEWINTER, MARTIN M · 2014 to 2017
$2.5M
Sarcolemmal Calcium Extrusion Defect in Patients with Diastolic DysfunctionR01HL122744 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI LUSTGARTEN, DANIEL L, MEYER, MARKUS · 2015 to 2019
$1.9M
NHLBI NIH HHS R01 HL118524NHLBI NIH HHS R01 HL122744
6 · The paper itself

Abstract

Background Increases in heart rate are thought to result in incomplete left ventricular (LV) relaxation and elevated filling pressures in patients with heart failure with preserved ejection fraction (HFpEF). Experimental studies in isolated human myocardium have suggested that incomplete relaxation is a result of cellular Ca

Indexed as

AgedAtrial FibrillationCalciumCase-Control StudiesCatheter AblationFemaleHeart AtriaHeart FailureHeart RateHeart VentriclesHumansHypertensionMaleMiddle AgedMyocardiumSodiumCalciumSodiumCa2+ cycling/excitation-contraction couplingheart failurehypertensionion channels/membrane transportmechanisms

Identifiers

PMID32856526
PMCPMC7660766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.